China Fund Positioning Analysis, June 2023

257 China Equity Funds, AUM $94bn China Fund Positioning Analysis, June 2023 In this issue: China Consumer Staples: Conviction Overweight BYD Company Ltd: Rising Up The Ranks China A-Shares Stock Positioning Update 154 MSCI China Equity Funds, AUM $50bn China Consumer Staples: Conviction Overweight Active MSCI China managers break away from benchmarks as overweights close in on record levels. Time-Series …

Continue Reading

Copley Fund Research Fund Positioning Chart Pack II

1600 Active Equity Funds, AUM $4.7tr Fund Positioning Chart Pack BYD Co Ltd Becomes Most Popular Auto Stock in EM EM Fund Positioning: Qatar vs Saudi High Active in China. The Best Way to Beat The Benchmark? UK Tobacco: Kicking the Habit Netherlands Positioning: Extending Gains Asia Ex-Japan’s Unloved Stocks GEM, Asia Ex-Japan, China, China A-Shares BYD Co Ltd Becomes …

Continue Reading

GEM Fund Positioning Analysis, May 2023

375 emerging market Funds, AUM $400bn GEM Fund Positioning Analysis, May 2023 In this issue: Qatar: Momentum Stalls Consumer Discretionary: Active Rotation BYD Company: Moves to Top Auto Holding in EM Emerging Markets Stock Positioning Update 375 emerging market Funds, AUM $400bn Qatar: Momentum Stalls Fund exposure to Qatari stocks saw a strong increase between 2021 and 2022, but recent …

Continue Reading

Asia Ex-Japan Fund Positioning Analysis, May 2023

86 Asia Ex-Japan Equity Funds, AUM $54.5bn Asia Ex-Japan Fund Positioning Analysis, May 2023 Energy: Stalled Recovery BYD Company Limited: Record Holdings Asia Ex-Japan Stock Positioning Update 86 Asia Ex-Japan Equity Funds, AUM $54.5bn Energy: Stalled Recovery Active Asia Ex-Japan managers are reassessing their exposure to the Energy sector Time-Series & Sector Activity The recovery in Energy allocations among Asia …

Continue Reading

Copley Fund Research Fund Positioning Chart Pack

1600 Active Equity Funds, AUM $4.7tr Fund Positioning Chart Pack Global Funds: USA: Record Underweight as Shift to Europe Accelerates Emerging Market Funds: GQG EM Equity Fund: Breaking From The Pack Asia Ex-Japan Funds: Country/Sector Positioning Update China Funds: A-Share Financials: Avoiding the Tail UK Funds: The UK’s Most Wanted Stocks 354 GLOBAL EQUITY FUNDS, AUM $952BN USA: Record Underweight …

Continue Reading

UK Fund Positioning Analysis, May 2023

267 UK Equity Funds, AUM $184bn UK Fund Positioning Analysis, May 2023 Tobacco: Kicking the Habit HSBC Holdings: Conviction Returns UK Stock Positioning Update 267 UK Equity Funds, AUM $184bn Tobacco: Kicking the Habit Positioning in the Tobacco industry group falls to lowest levels in history. Time-Series & Industry Activity UK Fund ownership in the Tobacco industry group has fallen …

Continue Reading

Global Fund Positioning Analysis, May 2023

352 Global Equity Funds, AUM $962bn Global Fund Positioning Analysis, May 2023 Global Banks Deep Dive Netherlands Positioning: Extending Gains Stock Positioning Update   352 Global Equity Funds, AUM $962bn Global Banks Deep Dive Positioning in the Banking industry group stalls after US Banking failures, but non-US sentiment is improving.   Time-Series & Industry Positioning Among active Global equity funds, …

Continue Reading

UK Fund Positioning Analysis, April 2023

270 UK Equity Funds, AUM $179bn UK Equity Fund Positioning Analysis, April 2023 In this issue: Q1 Performance & Attribution Aerospace & Defense: Long-Term Decline Personnel Services: Fund Ownership Highs Oxford Instruments: Spike in Exposure   270 UK Equity Funds, AUM $179bn Q1 Performance & Attribution A look at Q1 performance and the drivers of performance among active UK Equity …

Continue Reading

Asia Ex-Japan Fund Positioning Analysis, April 2023

89 Active Asia Ex-Japan Funds, AUM $55bn Asia Ex-Japan Fund Positioning Analysis, April 2023 In this issue: Q1 Performance & Attribution Malaysia: Can’t Catch a Break Taiwan Banks: Un-Investible? Real Estate: Consolidating the Lows? 89 Active Asia Ex-Japan Funds, AUM $55bn Q1 Performance & Attribution The latest stats on performance and the drivers of performance for Q1 2023. Active Asia …

Continue Reading

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley